prostate cancer therapeutics (OSE Pharma)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Nameprostate cancer therapeutics (OSE Pharma)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesOSE Immunotherapeutics SA
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOSE Immunotherapeutics SA
Active IndicationsN/A
Inactive IndicationsProstatic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A